Realcan Pharmaceutical Group Co (SZSE:002589) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:002589 Realcan Pharmaceutical Group Co Ltd SZSE:002589
48 GF Score
Price ¥3.53
GF Value ¥2.35
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Realcan Pharmaceutical Group Co Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

SZSE:002589 vs MCK, COR, CAH: Short Interest Comparison

For the Medical Distribution subindustry, Realcan Pharmaceutical Group Co's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Realcan Pharmaceutical Group Co Short Interest vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Realcan Pharmaceutical Group Co's Short Interest distribution charts can be found below:

* The bar in red indicates where Realcan Pharmaceutical Group Co's Short Interest falls into.


SZSE:002589
48GF Score
Realcan Pharmaceutical Group Co Ltd SZSE:002589
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Realcan Pharmaceutical Group Co (SZSE:002589) Overvalued in 2026?

Based on GuruFocus' analysis, Realcan Pharmaceutical Group Co stock appears to be overvalued. The current stock price of ¥3.53 is trading 50.2% above its estimated GF Value™ of ¥2.35. GuruFocus considers Realcan Pharmaceutical Group Co to be Significantly Overvalued.

Key valuation signals for SZSE:002589:

  • Short Interest:
  • GF Value™: ¥2.35 vs. price of ¥3.53 (50.2% above fair value)
  • GF Score™: 48/100 with 9 warning signs

No single metric tells the full story. See the SZSE:002589 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Realcan Pharmaceutical Group Co Business Description

Address No. 326, Airport Road, Zhifu District, Shandong Province, Yantai, CHN, 264004
Realcan Pharmaceutical Group Co Ltd is a Chinese company engaged in direct pharmaceuticals distribution services. The company's main business is divided into the Drug, vaccine, medical device circulation service; Medical industry third-party logistics; Medical information service; Medical logistics service; Chinese medicine plate; Hospital management sector; Medical industry research and development production sector; and Medical industry financial sector.
48GF Score

Get the complete analysis for SZSE:002589

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥3.53
Price
¥2.35
GF Value